Older patients are more susceptible to dehydration from gastrointestinal side effects and may have reduced thirst perception
8, 16087 doi: 10.1038/ncomms16087 (2017)
These effects contribute to its potential in mitigating key mechanisms underlying cardiovascular diseases (CVDs), such as oxidative stress, endothelial dysfunction, and inflammation
If you relate to any of the following, you may be a candidate for GLP-1 Agonist: BMI over 27 (or over 25 with an obesity-related condition like diabetes or high blood pressure) Previous difficulty losing and keeping weight off with diet, exercise, and/or other medications Ready for an extra push to boost your weight loss results Wanting to improve your health by losing excess body weight Our medical providers will thoroughly assess your health profile during a consultation to determine if GLP-1 Agonist is appropriate for your needs and goals
Of these, the mean difference between GLP-1 based therapies and controls in the percent changes from baseline were: 40.16 [51.50, 28.81] %